Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
- PMID: 14982744
- DOI: 10.1080/753312757
Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
Abstract
The presence of specific neuroinvasive strains and necessity for brain viral replication for disease progression remain controversial issues in neuro-AIDS research. To investigate these questions, the authors injected human monocyte-derived macrophages (MDMs) infected with diverse viral strains were injected into the caudate and putamen of severe combined immunodeficient (SCID) mice. Independent of viral strain, infected MDMs became immunologically activated and elicited profound inflammatory reactions in brain areas most affected in humans. The intensity of neuropathologic changes, including microglial reactions, paralleled levels of viral infection and numbers of infected MDMs. The data suggest that HIV-1-associated neurological disease is related to the level of productive viral infection in activated macrophages. Virus infection, per se, may affect the ability of macrophages to respond to immune stimuli by overproduction of proinflammatory factors and neurotoxins, leading to neuronal dysfunction.
Similar articles
-
Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.Glia. 2005 Dec;52(4):344-53. doi: 10.1002/glia.20253. Glia. 2005. PMID: 16078235
-
Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms.J Neurovirol. 2002 Dec;8 Suppl 2:49-52. doi: 10.1080/13550280290167993. J Neurovirol. 2002. PMID: 12491151 Review.
-
Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis.J Immunol. 2002 Apr 15;168(8):3941-9. doi: 10.4049/jimmunol.168.8.3941. J Immunol. 2002. PMID: 11937550
-
Microglia in HIV-associated neurological diseases.Microsc Res Tech. 2001 Jul 15;54(2):95-105. doi: 10.1002/jemt.1124. Microsc Res Tech. 2001. PMID: 11455616 Review.
-
Human immunodeficiency virus encephalitis in SCID mice.Am J Pathol. 1996 Sep;149(3):1027-53. Am J Pathol. 1996. PMID: 8780406 Free PMC article.
Cited by
-
Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.Mol Pharm. 2015 Dec 7;12(12):4226-36. doi: 10.1021/acs.molpharmaceut.5b00424. Epub 2015 Nov 13. Mol Pharm. 2015. PMID: 26565115 Free PMC article.
-
Amphiphilic cationic nanogels as brain-targeted carriers for activated nucleoside reverse transcriptase inhibitors.J Neuroimmune Pharmacol. 2015 Mar;10(1):88-101. doi: 10.1007/s11481-014-9576-7. Epub 2015 Jan 6. J Neuroimmune Pharmacol. 2015. PMID: 25559020 Free PMC article.
-
Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.J Neuroimmunol. 2013 Dec 15;265(1-2):117-23. doi: 10.1016/j.jneuroim.2013.09.005. Epub 2013 Sep 27. J Neuroimmunol. 2013. PMID: 24210837 Free PMC article.
-
Rodent models for HIV-associated neurocognitive disorders.Trends Neurosci. 2012 Mar;35(3):197-208. doi: 10.1016/j.tins.2011.12.006. Epub 2012 Feb 1. Trends Neurosci. 2012. PMID: 22305769 Free PMC article. Review.
-
HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA.PLoS One. 2011;6(6):e21261. doi: 10.1371/journal.pone.0021261. Epub 2011 Jun 21. PLoS One. 2011. PMID: 21712995 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical